Cargando…

SAT-018 Androgen Actions in Adipose Tissue and the Brain Are Key Mediators in the Development of Polycystic Ovary Syndrome

Polycystic ovary syndrome (PCOS) is a complex disorder characterised by endocrine, reproductive and metabolic abnormalities. Despite PCOS being the most common endocrinopathy affecting women of reproductive age, its etiology is poorly understood so there is no cure and symptom-oriented treatment is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cox, Madeleine J, Edwards, Melissa C, Aflatounian, Ali, Paris, Valentina Rodriguez, Ledger, William L, Gilchrist, Robert B, Handelsman, David J, Walters, Kirsty A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Reproductive Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207929/ http://dx.doi.org/10.1210/jendso/bvaa046.088

Ejemplares similares

OR08-2 Androgen Receptor- Vs Estrogen Receptor-Mediated Actions in the Development of Distinct Clinical Polycystic Ovary Syndrome (PCOS) Phenotypes
por: Aflatounian, Ali, et al.
Publicado: (2019)

MON-231 Dietary Interventions Can Ameliorate Polycystic Ovary Syndrome (PCOS) Traits in a PCOS Mouse Model
por: Rodriguez Paris, Valentina, et al.
Publicado: (2019)

SUN-018 No Difference in Breastfeeding Rates in Women with Polycystic Ovary Syndrome
por: Bui, Leeann, et al.
Publicado: (2020)

SAT381 Effect of Obesity on Androgen-induced Splenic Dysregulation in Polycystic Ovary Syndrome
por: Rezq, Samar, et al.
Publicado: (2023)

Androgen receptor splice variants and polycystic ovary syndrome: cause or effect?
por: Walters, Kirsty A, et al.
Publicado: (2016)

SAT-024 Investigating Racial and Ethnic Comorbidity Patterns of Polycystic Ovary Syndrome
por: Actkins, Ky’Era, et al.
Publicado: (2020)

SAT-224 Polycystic Ovary Syndrome with Adrenal Hyperandrogenemia and Refractory Hirsutism
por: Parveen, Sanober, et al.
Publicado: (2019)

MON-022 Dissecting the Interplay Between Diet and PCOS Pathology on Gut Microbiota in a PCOS Mouse Model
por: Paris, Valentina Rodriguez, et al.
Publicado: (2020)

SAT370 Economic Burden of Endometrial Cancer Associated with Polycystic Ovary Syndrome
por: Pace, Lauren Arielle, et al.
Publicado: (2023)

SAT-017 Relationship Between Vitamin D Levels and Signs of Polycystic Ovary Syndrome
por: Smykalova, Anastasia, et al.
Publicado: (2020)

SAT353 Relevance of Ovarian Morphology Among Adolescents With Polycystic Ovary Syndrome (PCOS)
por: Christ, Jacob P, et al.
Publicado: (2023)

SAT390 Western Diet Exacerbates Colonic Mitochondrial Dysfunction in the Hyperandrogenemic Female Rat Model of Polycystic Ovary Syndrome
por: Edwards, Kristin, et al.
Publicado: (2023)

SAT388 Does Obesity Drive the Development of Polycystic Ovary Syndrome (PCOS)? An Epidemiologic Study
por: Amiri, Mina, et al.
Publicado: (2023)

Pathogenesis of Reproductive and Metabolic PCOS Traits in a Mouse Model
por: Rodriguez Paris, Valentina, et al.
Publicado: (2021)

SAT-015 Incidence and Predictors of Hypertension in a Cohort of Australian Women with and Without Polycystic Ovary Syndrome
por: Kakoly, Nadira Sultana, et al.
Publicado: (2020)

SAT372 Obstructive Sleep Apnea (OSA) Risk Among Patients With Polycystic Ovary Syndrome (PCOS)
por: Christ, Jacob P, et al.
Publicado: (2023)

SAT356 Predicting Nonalcoholic Fatty Liver Disease in Adolescent Girls with Polycystic Ovary Syndrome and Obesity
por: Lo, Jaclyn S, et al.
Publicado: (2023)

SAT357 Rising Incidence, Health Resource Utilization and Costs of Polycystic Ovary Syndrome in the United Kingdom
por: Berni, Tom, et al.
Publicado: (2023)

SAT-023 Osteosarcopenia in Reproductive-Aged Women with Polycystic Ovary Syndrome: A Multicenter Case-Control Study
por: Kazemi, Maryam, et al.
Publicado: (2020)

SAT485 Knockout Of TLR4 Alters Reproductive And Metabolic Outcomes In Mouse Model Of Polycystic Ovary Syndrome
por: Dominique Wiggins, Kiara, et al.
Publicado: (2023)

SUN-019 Androgens Modulate Lipid Metabolism and Absorption in Control and Polycystic Ovary-Metabolic Syndrome Conditions
por: Vine, Donna Faye, et al.
Publicado: (2020)

Metabolic PCOS Features Are Ameliorated by Mitochondrial Uncoupler BAM15 in a PCOS Mouse Model
por: Paris, Valentina Rodriguez, et al.
Publicado: (2021)

SAT366 Expression of Amyloid-related Proteins Associated With Dementia in Polycystic Ovary Syndrome Compared to a Control Population
por: Butler, Alexandra E, et al.
Publicado: (2023)

MON-223 Adipose Insulin Resistance in Normal-Weight Women with Polycystic Ovary Syndrome
por: Hoyos, Luis, et al.
Publicado: (2019)

OR35-02 Novel Androgen Receptor PROTAC Degrader ARV-110 Ameliorates Androgen Mediated Renal Injury in a Mouse Model of Polycystic Ovary Syndrome
por: Basnet, Jelina, et al.
Publicado: (2023)

MON-LB010 Cyclic Progesterone Therapy for Androgenic Polycystic Ovary Syndrome (PCOS) - A Systematic Review of the Literature
por: Shirin, Sonia, et al.
Publicado: (2020)

SAT-213 Late Diagnosis of Complete Androgen Insensitivity
por: Tsai, Karen, et al.
Publicado: (2019)

RF10 | PMON249 MicroRNA-21 Ablation Exacerbates Androgen-Mediated White Adipose Tissue Dysfunction and Impaired Insulin Signaling in a Mouse Model of Polycystic Ovary Syndrome
por: Rezq, Samar, et al.
Publicado: (2022)

SAT-LB042 Effect of Dehydroepiandrosterone on the Perimenopausal Ovary
por: Luna, Selva, et al.
Publicado: (2019)

SAT363 The Prevalence And Phenotype Of Polycystic Ovary Syndrome (PCOS) In A Community-Based Population In Sub-Sahara Africa: The Nigeria-PEP Study
por: Makwe, Christian Chigozie, et al.
Publicado: (2023)

SAT373 A Systematic Review and Meta-Analysis Show Body Image Concerns Are Significantly Higher in Women and Individuals With Polycystic Ovary Syndrome
por: Kempegowda, Punith, et al.
Publicado: (2023)

MON-LB038 Reduced Exercise Endurance And Skeletal Muscle Alterations In A Prenatally Androgenized Rat Model For Polycystic Ovary Syndrome
por: DeChick, Auryana, et al.
Publicado: (2019)

MON-LB9 Cyclic Progesterone Therapy in Androgenic Polycystic Ovary Syndrome (PCOS) - Person-Related 6-Month Experience Changes
por: Shirin, Sonia, et al.
Publicado: (2020)

SAT365 Prevalence of Polycystic Ovary Syndrome (PCOS) in Health System and Insurer Records vs. the Prevalence in the Population: Evidence for the Significant Underdiagnosis and Undertreatment of PCOS
por: Hatoum, Sana, et al.
Publicado: (2023)

Genetic Sex Effects of Polycystic Ovary Syndrome Reveal Distinct Metabolic Etiology
por: Actkins, Ky’Era, et al.
Publicado: (2021)

SAT-195 Oocyte-Secreted Factors GDF9 and BMP15 Measured in Serum Correlate with Reproductive Potential in Women
por: Riepsamen, Angelique, et al.
Publicado: (2019)

MRNA Expression of Adipocytokines and Glucose Transporter Type 4 (GLUT4) in Adipose Tissue in Women With and Without Polycystic Ovary Syndrome
por: Ozga, Katarzyna Maria, et al.
Publicado: (2021)

MicroRNA-21 Modulates White Adipose Tissue Browning and Altered Thermogenesis in a Mouse Model of Polycystic Ovary Syndrome
por: Rezq, Samar, et al.
Publicado: (2021)

OR35-05 Interaction of Cortisol with Testosterone Predicts Abdominal Fat Mass in Normal-weight Polycystic Ovary Syndrome Women with Normal Serum 11-Oxygenated Androgens
por: Anthony Dumesic, Daniel, et al.
Publicado: (2023)

OR33-1 Metabolic Inflexibility in Obese versus Lean Women with Polycystic Ovary Syndrome (PCOS): Is PCOS Status or Adiposity the Critical Factor?
por: Gebara, Nour, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d5rsgk4m7v5jjh4haimubgce1b